Effects of tobacco smoking on HIV-infected individuals

AIDS Reviews

Volumn 17, Issue 1, 2014, Pages

  Calvo, Marta ^a   Laguno, Montserrat ^a   Martínez, María ^a   Martínez, Esteban ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cancer; Cardiovascular disease; HIV infection; Nicotine; Oxidative stress; Tobacco cigarette smoking

Indexed keywords

BONE METABOLISM; CANCER RISK; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; METABOLISM; PATHOPHYSIOLOGY; REPRODUCTIVE HEALTH; REVIEW; SMOKING; SMOKING CESSATION;

EID: 84928192657     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Wallace J, Rao A, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. Am Rev Respir Dis. 1993;148:1523-9.
2. Lifson A, Neuhaus J, Arribas J, van den Berg-Wolf M, Labriola A, Read T. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010;100:1896-903.
3. Tesoriero J, Gieryic S, Carrascal A, Lavigne H. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824-35.
4. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General, 2014. Available at: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/
5. CDC C for DC and P. Diagnoses of HIV Infection in the United States and Dependent Areas, 2011. HIV Surveillance Report, Volume 23. 2011. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance-report-vol-23.html
6. Marshall M, McCormack M, Kirk G. Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev. 2009;21:28-39.
7. May M, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy: UK cohort study. AIDS. 2014;28:1193-202.
8. Phillips A, Neaton J, Lundgren J. The role of HIV in serious diseases other than AIDS. AIDS. 2008;22:2409-18.
9. Crothers K, Goulet J, Rodriguez-Barradas M, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev. 2009;21:40-53.
10. Helleberg M, May M, Ingle S, Dabis F, Reiss P, Fätkenheuer G. Impact of Smoking on Life Expectancy among HIV-Infected Individuals: The ART Cohort Collaboration on behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC). CROI, Boston, 2014. [Poster 559].
11. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53:1130-9.
12. Helleberg M, Afzal S, Kronborg G, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727-34.
13. Shuter J, Bernstein S. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10:731-6.
14. Feldman J, Minkoff H, Schneider M, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006;96: 1060-5.
15. Hershberger S, Fisher D, Reynolds G, Klahn J, Wood M. Nicotine dependence and HIV risk behaviors among illicit drug users. Addict Behav. 2004;29:623-5.
16. Chander G, Lau B, Moore R. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43:411-7.
17. Earla R, Ande A, McArthur C, Kumar A, Kumar S. Enhanced nicotine metabolism in HIV-1-positive smokers compared with HIV-negative smokers: simultaneous determination of nicotine and its four metabolites in their plasma using a simple and sensitive electrospray ionization liquid chromatography-tandem ma. Drug Metab Dispos. 2014;42:282-93.
18. Pal D, Kwatra D, Minocha M, Paturi D, Budda B, Mitra A. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sciences. 2011;88:959-71.
19. Ande A, McArthurc C, Kumar A, Kumar S. Tobacco smoking effect on HIV-1 pathogenesis: Role of cytochrome P450 isozymes. Expert Opin Drug Metab Toxicol. 2013;9:1453-64.
20. International Agency for Research of Cancer. WHO. Smokeless tobacco and tobacco-specific nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: WHO, 2007:421-583. Available at: http://monographs.iarc.fr/ENG/recentpub/mono89.pdf
21. Benowitz N, Hukkanen J, Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;192:29-60.
22. Cloëz-Tayarani I, Changeux J-P. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81:599-606.
23. Khanna A, Guo M, Mehra M, Royal W. Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013;254:69-75.
24. Pandey R, Singh M, Singhal U, Gupta K, Aggarwal S. Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease. J Clin Diagn Res. 2013;7:580-8.
25. Harrison C, Pompilius M, Pinkerton K, Ballinger S. Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production. Environ Health Perspect. 2011;119:676-81.
26. Kosmider B, Messier E, Chu H, Mason R. Human alveolar epithelial cell injury induced by cigarette smoke. PLoS One. 2011;6:e26059.
27. Mazzone P, Tierney W, Hossain M, Puvenna V, Janigro D, Cucullo L. Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area. Int J Environ Res Public Health. 2010;7:4111-26.
28. López S, Miró O, Martínez E, et al. Mitochondrial effects of antiretroviral therapies in asymptomatic patients. Antivir Ther. 2004;9:47-55.
29. Salmen S, Berrueta L. Immune Modulators of HIV Infection: The Role of Reactive Oxygen Species. J Clin Cell Immunol. 2012;03.
30. Shammas M. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14:28-34.
31. Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res. 2012;91:142-9.
32. Park L, Margolick J, Giorgi J, et al. Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1992;5:1124-30.
33. Royce R, Winkelstein W. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS. 1990;4:327-33.
34. Montarroyos U, Miranda-Filho D, César C, et al. Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis. PLoS One. 2014;9:e84276.
35. Shirley D, Kesari R, Glesby M. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS. 2013;27:604-12.
36. Rock R, Gekker G, Aravalli R, Hu S, Sheng W, Peterson P. Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol. 2008;3:143-9.
37. Zhao L, Li F, Zhang Y, et al. Mechanisms and genes involved in enhancement of HIV infectivity by tobacco smoke. Toxicology. 2010;278:242-8.
38. Jin M, Earla R, Shah A, Earla R, Gupte R, Mitra A. A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. J Neuroimmune Pharmacol. 2012;7:289-99.
39. Zanet D, Thorne A, Singer J, Maan E, Sattha B, Le Campion A. Association between short leukocyte telomere length and HIV infection in a cohort study: no evidence of a relationship with antiretroviral therapy. Clin Infect Dis. 2014;58:1322-32.
40. De Marco F. Oxidative stress and HPV carcinogenesis. Viruses. 2013;5:708-31.
41. Besaratinia A, Tommasi S. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions. FASEB J. 2013;27:2090-100.
42. Hecht S. Lung carcinogenesis by tobacco smoke. Int J Cancer. 2012;131:2724-32.
43. Wittel U, Momi N, Seifert G, Wiech T, Hopt U, Batra S. The pathobiological impact of cigarette smoke on pancreatic cancer development. Int J Oncol. 2012;41:5-14.
44. Ding L, Getz G, Wheeler D, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455:1069-75.
45. Adcock I, Caramori G, Barnes P. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265-84.
46. Brown K, Perry H, Lau J, et al. Nicotine induces the up-regulation of the α7-nicotinic receptor (α7-nAChR) in human squamous cell lung cancer cells via the Sp1/GATA protein pathway. J Biol Chem. 2013;288: 33049-59.
47. Moktar A, Singh R, Vadhanam M, et al. Cigarette smoke condensate-induced oxidative DNA damage and its removal in human cervical cancer cells. Int J Oncol. 2011;39:941-7.
48. Sinha P, Logan H, Mendenhall W. Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol. 2012;33:130-6.
49. Engels E. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS. 2009;23:875-85.
50. Helleberg M, Gerstoft J, Afzal S, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014;28:1499-508.
51. Mullins T, Wilson C, Rudy B, Sucharew H, Kahn J. Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States. Sex Transm Dis. 2013;40:715-20.
52. Beachler D, D'Souza G. Natural history of oral papillomavirus infection in men. Lancet. 2013;382:839-41.
53. Shiels M, Cole S, Mehta S, Kirk G. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr. 2010;55:510-5.
54. Wistuba I, Behrens C, Milchgrub S, et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998;279:1554-9.
55. The Framingham Heart Study Collaborators. The Framingham Heart Study. 2014. Available at: http://www.framinghamheartstudy.org/
56. Gellert C, Schöttker B, Müller H, Holleczek B, Brenner H. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults. Eur J Epidemiol. 2013;28:649-58.
57. Valenti V, Vanderlei L, Ferreira C, et al. Sidestream cigarette smoke and cardiac autonomic regulation. Int Arch Med. 2013;6:11.
58. Lee J, Cooke J. Nicotine and pathological angiogenesis. Life Sci. 2012;91:1058-64.
59. Naem E, Alcalde R, Gladysz M, et al. Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: A potential mechanism for smoking-associated hypoalphalipoproteinemia. Life Sci. 2012;91:64-9.
60. Audrain-McGovern J, Benowitz N. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;90:164-8.
61. Liu T, Chen W-Q, David S, et al. Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol. 2011;165:961-7.
62. Togna A, Latina V, Orlando R, Togna G. Cigarette smoke inhibits adenine nucleotide hydrolysis by human platelets. Platelets. 2008;19:537-42.
63. Bucher H, Richter W, Glass T, et al. Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2012;60:135-42.
64. Triant V, Regan S, Lee H, Sax P, Meigs J, Grinspoon S. Association of immunologic and virologic factors with myocardial infarction rates in a US Healthcare System. J Acquir Immune Defic Syndr. 2010;55:615-9.
65. Subramanian S, Tawakol A, Burdo T, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308:379-86.
66. Stanley T, Grinspoon S. Body composition and metabolic changes in HIV-infected patients. J Infect Dis. 2012;205(Suppl 3):S383-90.
67. Grunfeld C, Delaney J, Wanke C, et al. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS. 2009;23:1841-9.
68. Savès M, Chêne G, Ducimetière P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292-8.
69. Calvo-Sánchez M, Perelló R, Pérez I, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Med. 2013;14:40-8.
70. Fitch K, Looby S, Rope A, et al. Effects of aging and smoking on carotid intima media thickness in HIV-infection. AIDS. 2013;27:49-57.
71. Unsal A, Abd-Elmoniem K, Eshera S, Purdy J, Hazra R, Hadigan C. Antiviral therapy and smoking associated with coronary vessel thickening in HIV-Infected Youth. CROI, Boston, 2014.
72. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8:36.
73. Mayo L, Quintana F, Weiner H. The innate immune system in demyelinating disease. Immunol Rev. 2012;248:170-87.
74. Wendelken L, Valcour V. Impact of HIV and aging on neuropsychological function. J Neuro Virol. 2012;18:256-63.
75. Garvey L, Surendrakumar V, Winston A. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. HIV Clin Trials. 2011;12:333-8.
76. Fabbiani M, Ciccarelli N, Tana M, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med. 2013;14:136-44.
77. Manda V, Mittapalli R, Bohn K, Adkins C, Lockman P. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem. 2010;115:1495-507.
78. Durazzo T, Rothlind J, Cardenas V, Studholme C, Weiner M, Meyerhoff D. Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology. Alcohol. 2007;41:489-501.
79. Wong P, Christie J, Wark J. The effects of smoking on bone health. Clin Sci (Lond). 2007;113:233-41.
80. Walker Harris V, Brown T. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis. 2012;205(Suppl 3):S391-8.
81. Young B, Dao C, Buchacz K, Baker R, Brooks J. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis. 2011;52:1061-8.
82. Coll O, Lopez M, Vidal R, et al. Fertility assessment in non-infertile HIV-in-fected women and their partners. Reprod Biomed Online. 2007; 14:488-94.
83. Kushnir V, Lewis W. Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals. Fertil Steril. 2011;96:546-53.
84. López S, Coll O, Durban M, et al. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women. Antivir Ther. 2008;13:833-8.
85. Doshi S, Khullar K, Sharma R, Agarwal A. Role of reactive nitrogen species in male infertility. Reprod Biol Endocrinol. 2012;10:109.
86. Soares S, Melo M. Cigarette smoking and reproductive function. Curr Opin Obstet Gynecol. 2008;20:281-91.